Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

Annals of Neurology

Volumn 42, Issue 5, 1997, Pages 679-688

  Ellis, Ronald J ^a,e   Hsia, Karen ^b   Spector, Stephen A ^b   Nelson, Julie A ^b   Heaton, Robert K ^b   Wallace, Mark R ^c   Abramson, Ian ^b   Atkinson, J Hampton ^b,d   Grant, Igor ^b,d   McCutchan, J Allen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PLEOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HIV-1; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROTEASE INHIBITORS; RNA, VIRAL;

EID: 15144358328     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420503     Document Type: Article

References (51)

1. DiStefano M, Monno L, Fiore JR, Angarano G. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis. AIDS 1997;11:133-135
2. Wiley CA, Baldwin M, Achim CL. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 1996;10:843-847
3. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-676
4. Saksena NK, Wang B, Ge YC, et al. Region-specific changes, gene duplications, and random deletions in the nef gene from HIV type 1-infected brain tissues and blood of a demented patient. AIDS Res Hum Retroviruses 1997;13:111-116
5. Peeters MF, Colebunders RL, Van den Abbeele K, et al. Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and peripheral blood. J Med Virol 1995;47:92-96
6. Di Stefano M, Gray F, Leitner T, Chiodi F. Analysis of ENV V3 sequences from HIV-1-infected brain indicates restrained virus expression throughout the disease. J Med Virol 1996;49: 41-48
7. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996;10:951-958
8. de Luca A, Cingolani A, Linzalone A, et al. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 1996;34:1343-1346
9. Vago L, Cinque P, Sala E, et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:139-146
10. Weber T, Turner RW, Frye S, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-1141
11. Nguyen LN, Kox LF, Pham LD, et al. The potential contribution of the polymerase chain reaction to the diagnosis of tuber-culous meningitis. Arch Neurol 1996;53:771-776
12. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-1497
13. Hollander H, Levy JA. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med 1987;106:692-695
14. Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988;38:9-14
15. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992;30:1768-1771
16. Spector SA, Hsia K, Pratt D, et al. Virologie markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. J Infect Dis 1993; 168:68-74
17. Pratt RD, Nichols S, McKinney N, et al. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996;174:288-293
18. Appleman ME, Marshall DW, Brey RL, et al. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis 1988; 158:193-199
19. Elovaara I, Seppäl I, Poutiainen E, Suni J, Valle SL. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 1988;38:1451-1456
20. McArthur JC, Cohen BA, Farzedegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988;23(suppl):S34-S37
21. Gisslén M, Chiodi F, Fuchs D, et al. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 1994;26:523-533
22. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-534
23. Stanley S, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-1230
24. Schmid P, Conrad A, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1994;7:777-788
25. Steuler H, Munzinger S, Wildemann B, Storch-Hagenlocher B. Quantitation of HIV-1 proviral DNA in cells from cerebrospinal fluid. J Acquir Immune Defic Syndr 1992;5:405-408
26. Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300
27. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579
28. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologie and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med 1996;335: 1091-1098
29. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-I RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-431
30. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:425-435
31. Brew BJ, Pemberton L, Cunningham P, Law M. Cerebrospinal fluid HIV-1 RNA levels correlate with AIDS dementia complex. XI International Conference on AIDS. Vancouver, British Columbia, Canada: 1996
32. Lanier ER, McClernon D, Stocum M, et al. CSF HIV RNA: Relationship to HIV-associated neurological disease. XI International Conference on AIDS. Vancouver, British Columbia, Canada: 1996
33. Heaton R, Grant I, Butters N, et al. The HNRC 500: Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995;1:231-251
34. Carson D, Serpell M. Choosing the best needle for diagnostic lumbar puncture. Neurology 1996;47:33-37
35. Blennow K, Fredman P, Wallin A, et al. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 1993;33:129-133
36. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17):1-19
37. Butters N, Grant I, Haxby J, et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol 1990;12:963-978
38. Heaton RK, Kirson D, The HNRC Group. The utility of clinical ratings for detecting cognitive change in HIV infection. In: Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press, 1994;188-206
39. Heaton RK. Comprehensive norms for an expanded Halstead-Reitan Battery: a supplement for the WAIS-R. Odessa, FL: Psychological Assessment Resources, 1992
40. Heaton RK, Grant I, Mathews CG. Comprehensive norms for an expanded Halstead-Reitan Battery: demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources, 1991
41. Heaton RK, Grant I, Anthony WZ, Lehman RA. A comparison of clinical and automated interpretation of the Halstead-Reitan Battery. J Clin Neuropsychol 1981;3:121-141
42. Filley CM, Heaton RK, Thompson LL, et al. Effects of disease course on neuropsychological functioning. In: Rao SM, ed. Neurobehavioral aspects of multiple sclerosis. New York, NY: Oxford University Press, 1990:136-148
43. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-785
44. SPSS 6.1: Macintosh version. Chicago: SPSS, Inc., 1994
45. Reiber H, Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987;163:319-328
46. Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988;45:954-958
47. Margolick JB, McArthur JC, Scott ER, et al. Flow cytometric quantitation of T cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus, type I. J Neuroimmunol 1988;20:73-81
48. McArthur JC, Sipos E, Cornblath DR, et al. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989;39:66-70
49. Sei S, Stewart SK, Farley M, et al. Evaluation of human immunodeficiency virus (HIV) type I RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996;174:1200-1206
50. Goswami KK, Miller RF, Harrison MJ, et al. Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 1991;5:797-803
51. Foudraine N, DeWolf F, Hoetelmans R, et al. CSF and serum HIV-RNA levels during AZT/3TC and d4T/3TC treatment. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections. Washington, DC: July 1997 (Abstract)